CPC A61K 39/39 (2013.01) [A61K 39/00 (2013.01); A61P 37/04 (2018.01); C07D 239/49 (2013.01); A61K 2039/505 (2013.01)] | 27 Claims |
1. A method of inducing or enhancing an antigen-specific immune reaction in a mammal, wherein the method comprises administering to the mammal in need thereof an effective amount of a compound selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.
|